查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1624404

全球一次性生物加工市場規模（按地區、範圍和預測）

Global Single-Use Bioprocessing Market Size By Product (Containers, Media bags), By Workflow (Upstream, Fermentation, Downstream), By End Use (Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

一次性生物加工市場規模及預測

2021 年一次性生物加工市場規模價值 110.5 億美元，預計到 2030 年將達到 151 億美元，2022 年至 2030 年的複合年增長率為 18.02%。生物製藥需求不斷增長、能源效率高、用水量低、佔地面積小、產品交叉污染風險低以及實施速度快是一次性生物處理的一些關鍵優勢。全球市場。全球對生物製藥的需求正在快速成長。許多大公司正積極投資生物製藥及其相關產品。推動需求成長的最大因素之一是老齡人口的成長和慢性病的流行。因此，預計全球一次性生物加工市場在整個預測期內將大幅成長。

定義全球一次性生物加工市場

多種生物處理技術均採用一次性培養基袋及容器。此外，生物製藥和生物製造領域經常使用一次性容器來進行關鍵的液體處理應用。單株抗體（mAb）採用一次性生物加工技術製造，因此該領域在全球一次性生物加工市場中佔據主導地位。由於一次性技術 (SUT) 帶來的好處（包括顯著減少資本成本和設施建設時間），生物加工中一次性產品的使用急劇增加。因此，一次性生物加工市場正在經歷兩位數的成長。

全球老年人口的成長可能會在未來幾年推動市場擴張。根據聯合國預測，到2050年，全球預計將有約15億人口年齡在65歲或以上。人口老化容易促使慢性疾病，這可能會大幅增加對生物製藥的需求和消費，從而刺激全球一次性生物加工市場的擴張。

一次性生物處理的全球市場概況

許多最終用戶將一次性系統 (SUS) 視為實現最高水準生產力和流程效率的經濟可行策略。因此，SUS 設備廣泛應用於生物製造的各個階段，尤其是在商業化前生物製藥的生產中。這反過來又為該行業的產品提供者創造了商機。

影響一次性生物加工市場的關鍵趨勢之一是，為生物製藥的商業合成提供耐用一次性用品的供應商數量不斷增加。大數據分析預計將成為主導趨勢。透過實現預測和製程參數，採用基於大數據機器學習的分析模型可望提高產品產量。由於 SUT 在需要快速週轉時間的多產品生物加工中易於使用且有效，CMO 現在看到一次性用品的採用率顯著提高。一次性生物加工市場受到製藥業日益增長的需求的嚴重影響。大多數生物製藥公司擴大採用一次性生物加工系統，因為它們可以提高製程效率並降低鋼製生物反應器的滅菌、清潔和維護成本。一次性生物處理系統用於各種生物製藥應用，包括混合、過濾、淨化和儲存。生物製藥產業也在快速擴張。生物製藥約佔全球醫藥市場的20%。

目錄

第 1 章 全球一次性生物加工市場簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章：經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第 4 章全球一次性生物加工市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球一次性生物加工市場（依產品劃分）

  • 概述
  • 容器
  • 媒體包

第6章全球一次性生物處理市場（按應用）

  • 概述
  • 上游
  • 發酵
  • 下游

第7章 全球一次性生物處理市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第 8 章全球一次性生物加工市場：競爭格局

  • 概述
  • 各公司的市場排名
  • 主要發展策略

第9章 公司簡介

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Sartorius AG
  • Corning Incorporated
  • Pall Corporation
  • General Electric Company（GE Healthcare）
  • Eppendorf AG
  • Lonza
  • Meissner Filtration Products, Inc.
  • JM BioConnect

第 10 章附錄

    • 相關報告
簡介目錄
Product Code: 24194

Single-Use Bioprocessing Market Size And Forecast

Single-Use Bioprocessing Market size was valued at USD 11.05 Billion in 2021 and is projected to reach USD 15.1 Billion by 2030, growing at a CAGR of 18.02% from 2022 to 2030. Increasing demand for biopharmaceuticals, high energy efficiency, low tide usage, less floor space requirement, very low risk of product cross-contamination, and faster to implement are the key drivers for the expansion of the global single-use bioprocessing market. The global demand for biopharmaceuticals is rapidly increasing. Many leading pharmaceutical companies are actively investing in biopharmaceuticals and related products. One of the most significant drivers of this demanding hike is the growing elderly population and the prevalence of chronic conditions. Hence, throughout the forecast period, the global single-use bioprocessing market is expected to grow significantly faster.

Global Single-Use Bioprocessing Market Definition

Various bioprocessing techniques employ single-use media bags and containers. Additionally, the biopharmaceutical and biomanufacturing sectors frequently employ single-use containers for crucial liquid handling applications. Monoclonal antibodies (mAb) are produced using single-use bioprocessing technologies; as a result, this sector dominates the global single-use bioprocessing market. The usage of disposables has increased dramatically in the bioprocessing sector as a result of benefits provided by single-use technology (SUT), such as a considerable decrease in capital cost and facility building time. The market for single-use bioprocessing has grown by double digits as a result of this.

The expanding elderly population throughout the globe is likely to boost the market expansion in the following years. According to the United Nations, by 2050, it is predicted that roughly 1.5 billion of the global population would be of or over the age of 65 years. The senior population is more susceptible to chronic illnesses, thus there will be a significant increase in demand and consumption of biopharmaceutical drugs, which will fuel the expansion of the global single-use bioprocessing market.

Global Single-Use Bioprocessing Market Overview

Many end-users view single-use systems (SUS) as an economically feasible strategy to attain the highest level of productivity and process efficiency. SUS equipment is therefore extensively used throughout the biomanufacturing phases, but especially in the production of pre-commercial biopharmaceuticals. Opportunities have been generated for the industry's product providers as a result.

One of the key trends influencing the market for single-use bioprocessing is the growing number of suppliers providing durable disposables for the commercial synthesis of biopharmaceuticals. Big data analytics is expected to be the dominant trend. By enabling prediction and process parameters, the adoption of analytical models based on big data machine learning is projected to increase product yields. Due to the simplicity of use and effectiveness of SUTs in the bioprocessing of several products needing quick turnaround times, CMOs are currently adopting disposables at a significantly greater rate. The market for single-use bioprocessing is heavily influenced by the pharmaceutical industry's expanding need. Because single-use bioprocessing systems can boost process efficiency and lower the expenses involved with sterilizing, cleaning, and maintaining steel bioreactors, the majority of biopharmaceutical businesses are progressively implementing this technology. The single-use bioprocessing system is employed in a variety of biopharmaceutical applications, including mixing, filtering, purification, and storage. The biopharmaceutical industry is also expanding quickly. About 20% of the global pharma market is made up entirely of biopharmaceuticals.

Global Single-Use Bioprocessing Market: Segmentation Analysis

The Global Single-Use Bioprocessing Market is segmented based on Product, Workflow, End Use, And Geography.

Single-Use Bioprocessing Market, By Product

  • Containers
  • Media bags

Based on the Product, the global single-use bioprocessing market is divided into media bags and containers. In the market, single-use containers are more popular than single-use media bags. During the forecast period, the trend is expected to continue, offering the containers segment a leading market share of the global single-use bioprocessing market.

Single-Use Bioprocessing Market, By Workflow

  • Upstream
  • Fermentation
  • Downstream
  • The market is divided into upstream, fermentation, and downstream segments based on workflow. The single-use bioprocessing market is predicted to expand owing to the introduction of a wide array of SUS to be utilized throughout various phases of biomanufacturing. A significant portion of upstream processing has been facilitated by the use of SUS for cell culture, liquid handling, and storage.

Single-Use Bioprocessing Market, By End Use

  • Biopharmaceutical Manufacturer
  • Academic & Clinical Research Institutes
  • Others

Based on End Use, the market is bifurcated into Biopharmaceutical Manufacturer, Academic & Clinical Research Institutes, and Others. The biopharmaceutical manufacturing industry is expected to significantly benefit from the growing popularity of disposables among CMOS. Contract service providers are engaged in the expansion of single-use capacity by installing new Single-Use Bioprocessing products at their facility, thereby aiding in revenue regeneration.

Single-Use Bioprocessing Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • North America, Europe, Asia Pacific, Latin America (LATAM), the Middle East and Africa are the five main geographic divisions covered in the global single-use bioprocessing market report. The market for single-use bioprocessing is being adopted as a result of the growing need for biopharmaceuticals as well as its benefits, which include quick deployment, minimal risk of product cross-contamination, high energy efficiency, and low water consumption.

Key Players

  • The "Global Single-Use Bioprocessing Market" study report will provide valuable insight with an emphasis on the global market. The major players are
  • Thermo Fisher Scientific, Merck, Sartorius, Corning Incorporated, Pall Corporation, General Electric, Eppendorf, Rentschler Biopharma, Lonza, Meissner Filtration Products Inc., JM BioConnect, etc.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In March 2020: Danahar acquired the life sciences division of General Electric, Cytiva. Through this acquisition, Danahar is looking to expand its existing life sciences business and obtain a significant market share.
  • In September 2020: As a step towards expanding its life science business, Thermo Fisher Scientific did an investment of over 475 million at its St. Louis plant. The investment is mainly focused on carrying out research and development activities in several fields such as gene therapies, drug development, biopharmaceuticals, and biologics.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SINGLE USE BIOPROCESSING MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL SINGLE USE BIOPROCESSING MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Containers
  • 5.3 Media bags

6 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Upstream
  • 6.3 Fermentation
  • 6.4 Downstream

7 GLOBAL SINGLE USE BIOPROCESSING MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL SINGLE USE BIOPROCESSING MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Thermo Fisher Scientific, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Merck KGaA
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Sartorius AG
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Corning Incorporated
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Pall Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 General Electric Company (GE Healthcare)
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Development
  • 9.7 Eppendorf AG
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Lonza
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Meissner Filtration Products, Inc.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Development
  • 9.10 JM BioConnect
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Development

10 Appendix

    • 10.1.1 Related Reports